Enhertu Could Get Big Boost From Second-Line Breast Cancer Indication

 
• By Alaric DeArment
  
Doctor with Mammography - Image
AstraZeneca and Daiichi Sankyo announced positive topline results for Enhertu in second-line breast cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D